{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T11:08:32Z","timestamp":1791889712183,"version":"4.3.4"},"reference-count":148,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1998,6,1]],"date-time":"1998-06-01T00:00:00Z","timestamp":896659200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[1998,6]]},"DOI":"10.1007\/bf02786456","type":"journal-article","created":{"date-parts":[[2007,12,27]],"date-time":"2007-12-27T10:26:14Z","timestamp":1198751174000},"page":"345-368","source":"Crossref","is-referenced-by-count":56,"title":["Thymopentin and splenopentin as immunomodulators"],"prefix":"10.1007","volume":"17","author":[{"given":"Vijay K.","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumita","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna B.","family":"Mathur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wahajul","family":"Haq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satyendra K.","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam S.","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF02786456_CR1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0090-1229(87)90002-X","volume":"42","author":"PL Meroni","year":"1987","unstructured":"Meroni PL, Barcellini W, Frasca D, Sguotti C, Borghi M, De Bertolo G, Doria G, Zanussi C: In vivo immunopotentiating activity of thymopentin in aging humans: Increase of IL-2 production. Clin Immunol Immonupathol 1987; 42:151\u2013159.","journal-title":"Clin Immunol Immonupathol"},{"key":"BF02786456_CR2","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/0090-1229(88)90078-5","volume":"48","author":"W Barcellini","year":"1988","unstructured":"Barcellini W, Meroni PL, Borghi MO, Frasca D, Perego R, Doria G, Zanussi C: In vivo immunopotentiating receptor expression. Clin Immun Immunopathol 1988; 48:140\u2013149.","journal-title":"Clin Immun Immunopathol"},{"key":"BF02786456_CR3","first-page":"133","volume":"3","author":"C Caruso","year":"1989","unstructured":"Caruso C, Modica MA, Candore G, Di Lorenzo G, Durante M, Di Giulio C: In vivo thymopentin modulation of mitogen-responsiveness T cell precursor frequency. Int J Immunother 1989;3:133\u2013137.","journal-title":"Int J Immunother"},{"key":"BF02786456_CR4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0162-3109(86)90017-2","volume":"11","author":"D Frasca","year":"1986","unstructured":"Frasca D, Adorini L, Mancini C, Doria G: Reconstitution of T cell functions in aging by thymosin \u03b1 1. Immunopharmacology1986; 11: 155\u2013163.","journal-title":"Immunopharmacology"},{"key":"BF02786456_CR5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0008-8749(80)90438-4","volume":"15","author":"G Doria","year":"1980","unstructured":"Doria G, D\u2019Agostaro G, Garavini M: Age dependent changes of B cell reactivity and T cell T cell interaction in the in vitro antibody response. Cell Immunol 1980;15: 195\u2013206.","journal-title":"Cell Immunol"},{"key":"BF02786456_CR6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/247011a0","volume":"247","author":"G Goldstein","year":"1974","unstructured":"Goldstein G: Isolation of bovine thymin: a polypeptide hormone of the thymus. Nature 1974;247:11\u201314.","journal-title":"Nature"},{"key":"BF02786456_CR7","doi-asserted-by":"crossref","first-page":"6195","DOI":"10.1021\/bi00524a044","volume":"20","author":"T Audhya","year":"1981","unstructured":"Audhya T, Schlesinger DH, Goldstein G: Complete amino acid sequences of bovine thymopoietin I, II, III: closely homologous polypeptides. Biochemistry 1981 ;20: 6195\u20136200.","journal-title":"Biochemistry"},{"key":"BF02786456_CR8","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1136\/jnnp.31.5.453","volume":"31","author":"G Goldstein","year":"1968","unstructured":"Goldstein G, Hofmann WW: Electrophysiological changes similar to those of myasthenia gravis in rats with experimental autoimmune thymitis. J Neurol Neurosurg Psychiat 1968;31:453\u2013459.","journal-title":"J Neurol Neurosurg Psychiat"},{"key":"BF02786456_CR9","first-page":"181","volume":"4","author":"G Goldstein","year":"1969","unstructured":"Goldstein G, Hofmann WW: Endocrine function of the thymus affecting neuromuscular transmission. Clin Exp Immunol 1969; 4:181\u2013189.","journal-title":"Clin Exp Immunol"},{"key":"BF02786456_CR10","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1073\/pnas.71.4.1474","volume":"71","author":"RS Basch","year":"1974","unstructured":"Basch RS, Goldstein G: Induction of T cell differentiation in vitro by thymin, a purified polypeptide hormone of the thymus. Proc Natl AcadSciUSA 1974;71:1474\u20131478.","journal-title":"Proc Natl AcadSciUSA"},{"key":"BF02786456_CR11","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1084\/jem.147.6.1727","volume":"147","author":"MP Scheid","year":"1978","unstructured":"Scheid MP, Goldstein G, Bosyse EA: The generation and regulation of lymphocyte populations: Evidence from differentiative induction systems in vitro. J Exp Med 1978;147:1727\u20131743.","journal-title":"J Exp Med"},{"key":"BF02786456_CR12","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1084\/jem.148.4.996","volume":"148","author":"ME Weksler","year":"1978","unstructured":"Weksler ME, Innes JB, Goldstein G: Immunological studies of aging. IV. The contribution of thymic involution to the immune deficiencies of aging mice and reversal with thymopoietin32-36 J Exp Med 1978;148:996\u20131006.","journal-title":"J Exp Med"},{"key":"BF02786456_CR13","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/BF00350786","volume":"13","author":"EH Goldberg","year":"1981","unstructured":"Goldberg EH, Goldstein G, Boyse EA, Scheid MP: Effect of TP5 analogue of thymopoietin on the rejection of male skin by aged and thymectomized female mice. Immunogenetics 1981;13:201\u2013204.","journal-title":"Immunogenetics"},{"key":"BF02786456_CR14","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/00007890-198407000-00013","volume":"38","author":"EH Goldberg","year":"1984","unstructured":"Goldberg EH, Goldstein G, Harman DB, Boyse EA: Contrasting effects of thymopoietin and splenopentin on the capacity of female mice to reject syngeneic male skin. Transplantation 1984:38:52\u201355.","journal-title":"Transplantation"},{"key":"BF02786456_CR15","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.4049\/jimmunol.125.4.1634","volume":"125","author":"CY Lau","year":"1980","unstructured":"Lau CY, Freestone JA, Goldstein G: Effect of thymopoietin pentapeptide (TP-5) on autoimmunity. I. TP5 suppression of induced erythrocyte autoantibodies in C3H mice. J Immunol 1980;125:1634\u20131638.","journal-title":"J Immunol"},{"key":"BF02786456_CR16","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.4049\/jimmunol.124.4.1861","volume":"124","author":"CY Lau","year":"1980","unstructured":"Lau CY, Goldstein G: Functional effects of thymopoietin32-36(, (TP-5) on cytotoxic lymphocyte precursor units (CLP-U). Enhancement of splenic CLP-U in vitro and in vivo after suboptimal antigenic stimulation. J Immunol 1980;124:1861\u20131865.","journal-title":"J Immunol"},{"key":"BF02786456_CR17","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0008-8749(82)90174-5","volume":"66","author":"CY Lau","year":"1982","unstructured":"Lau CY, Wang EY, Goldstein G: Studies of thymopoietin pentapeptide (TP-5) on experimental tumors. I. TP-5 relieves immunosuppression in tumor-bearing mice. Cell Immunol 1982;66:217\u2013232.","journal-title":"Cell Immunol"},{"key":"BF02786456_CR18","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1126\/science.451537","volume":"204","author":"G Goldstein","year":"1979","unstructured":"Goldstein G, Scheid MP, Boyse EA, Schlesinger DH, Van Wauwe J: A synthetic pentapeptide with biological activity characteristic of thymic hormone thymopoietin. Science 1979;204:1309\u20131310.","journal-title":"Science"},{"key":"BF02786456_CR19","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1073\/pnas.81.9.2847","volume":"81","author":"T Audhya","year":"1984","unstructured":"Audhya T, Scheid MP, Goldstein G: Contrasting biological activities of thymopoietin and splenin, two closely related polypeptide products of thymus and spleen. Proc Natl Acad Sci USA 1984;81: 2847\u20132849.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02786456_CR20","first-page":"K9","volume":"43","author":"W Diezel","year":"1984","unstructured":"Diezel W, Waschke SR, Eckert R, Forner K: Induction and augmentation of mitogen-induced immune interferon production in human lymphocytes by a synthetic pentapeptide. Biomed Biochem Acta 1984;43:K9-K12.","journal-title":"Biomed Biochem Acta"},{"key":"BF02786456_CR21","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1055\/s-0029-1210547","volume":"87","author":"W Diezel","year":"1986","unstructured":"Diezel W, Eckert R, Forner K, Sonnichsen N: Effect of splenopentin (SP-5) on the antibody formation in immunosuppressed mice. Exp Clin Endocrinol 1986; 87:215\u2013218.","journal-title":"Exp Clin Endocrinol"},{"key":"BF02786456_CR22","first-page":"547","volume":"93","author":"W Diezel","year":"1989","unstructured":"Diezel W, Grumer S, Weber H, Maciejewski J, Volk HD: Synergistic effects of splenopentin and recombinant human granulocytemacrophage colony stimulating factor on myelopoiesis. J Invest Dermotol 1989;93:547.","journal-title":"J Invest Dermotol"},{"key":"BF02786456_CR23","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/BF00412738","volume":"281","author":"S Gruner","year":"1990","unstructured":"Gruner S, Deizel W, Strunk D, Zwirner A, Sonnichsen N, Anhalt GJ: Stimulation of recruitment of epidermal Langerhans cells by splenopentin. Arch Dermatol Res 1990;281:526\u2013529.","journal-title":"Arch Dermatol Res"},{"key":"BF02786456_CR24","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0092-8674(75)90054-9","volume":"5","author":"DH Schlesinger","year":"1975","unstructured":"Schlesinger DH, Goldstein G: The amino acid sequence of thymopoietin II. Cell 1975;5:361\u2013365.","journal-title":"Cell"},{"key":"BF02786456_CR25","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0092-8674(75)90055-0","volume":"5","author":"DH Schlesinger","year":"1975","unstructured":"Schlesinger DH, Goldstein G, Scheid MP, Boyse EA: Chemical synthesis of a peptide fragment of thymopoietin II that induces selective T cell differentiation. Cell 1975;5:367\u2013370.","journal-title":"Cell"},{"key":"BF02786456_CR26","doi-asserted-by":"crossref","first-page":"690","DOI":"10.4049\/jimmunol.117.2.690","volume":"117","author":"G Goldstein","year":"1976","unstructured":"Goldstein G: Radioimmunoassay for thymopoietin. J Immunol 1976; 117:690\u2013692.","journal-title":"J Immunol"},{"key":"BF02786456_CR27","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0008-8749(86)90031-6","volume":"100","author":"GI Viamontes","year":"1986","unstructured":"Viamontes GI, Audhya T, Goldstein G: Immunohistochemical localization of thymopoietin with an antiserum to its synthetic Cys-thymopoietin 28\u201339. Cell Immunol 1986;100:305\u2013313.","journal-title":"Cell Immunol"},{"key":"BF02786456_CR28","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1749-6632.1988.tb18811.x","volume":"548","author":"T Audhya","year":"1988","unstructured":"Audhya T, Goldstein G: Amino acid sequence of thymopoietin isolated from skin. Ann N Y Acad Sci 1988;548:233\u2013240.","journal-title":"Ann N Y Acad Sci"},{"key":"BF02786456_CR29","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0165-2478(92)90131-7","volume":"31","author":"D Zevin-Sonkin","year":"1992","unstructured":"Zevin-Sonkin D, Ilan E, Guthemann D, Riss J, Theodor L, Shoham J: Molecular cloning of the bovine thymopoietin gene and its expression on different calf tissues: Evidence for a predominant expression in thymocytes. Immunol Lett 1992;31:301\u2013309.","journal-title":"Immunol Lett"},{"key":"BF02786456_CR30","doi-asserted-by":"crossref","first-page":"6283","DOI":"10.1073\/pnas.91.14.6283","volume":"91","author":"CA Harris","year":"1994","unstructured":"Harris CA, Andryuk PJ Cline SW, Chan HK, Natarajan, A., Siekierka, JJ, Goldstein, G: Three distinct human thymopoietins are derived from alternatively spliced mRNAs. Proc Natl Acad Sci USA 1994;91: 6283\u20136287.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02786456_CR31","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1006\/geno.1995.1131","volume":"28","author":"CA Harris","year":"1995","unstructured":"Harris CA, Andryuk, PJ, Cline SW, Mathew S, Siekierka JL, Goldstein G: Structure and Mapping of the human thymopoietin (TMPO) gene and relationship of human TMPO beta to rat laminassociatedpolypeptide2. Genomics 1995;28:198\u2013205.","journal-title":"Genomics"},{"key":"BF02786456_CR32","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1101\/gr.6.5.361","volume":"6","author":"R Berger","year":"1996","unstructured":"Berger R, Theodor L, Shoham J, Gokkel E, Brok-Simoni F, Avraham KB, Copeland NG, Jenkins NA, Rechavi G, Simon AJ: The characterization and localization of the mouse thymopoietin\/lamin-associated polypeptide 2 gene and its alternatively spliced products. Genome Res 1996;6:361\u2013370.","journal-title":"Genome Res"},{"key":"BF02786456_CR33","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1159\/000204113","volume":"93","author":"R Berger","year":"1995","unstructured":"Berger R, Theodor L, BrokSimoni F, Ben-Bassat H, Trakhtenbrot J, Shoham S, Rechavi G: Demonstration of thymopoietin transcripts in different haematopoietic cell lines. Acta Haematol 1995;93:62\u201366.","journal-title":"Acta Haematol"},{"key":"BF02786456_CR34","first-page":"927","volume":"34","author":"H Hara","year":"1994","unstructured":"Hara H, Hayashi K, Ohta K, Itoh N, Ohta M: A new thymopoietin precursor gene from human thymus. Biochem Mol Biol Intl 1994;34: 927\u2013933.","journal-title":"Biochem Mol Biol Intl"},{"key":"BF02786456_CR35","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/elps.11501501144","volume":"15","author":"T Toda","year":"1994","unstructured":"Toda T, Ishijima Y, Matshusita H, Yoshida M, Kimura, N: Detection of thymopoietin-responsive proteins in nude mouse spleen cells by two-dimensional polyacrylamide gel electrophoresis and image processing. Electrophoresis 1994; 15:984\u2013987.","journal-title":"Electrophoresis"},{"key":"BF02786456_CR36","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1210\/jcem-47-1-145","volume":"47","author":"VM Lewis","year":"1978","unstructured":"Lewis VM, Twomey JJ, Bealmear P, Goldstein G, Boyse EA: Age, thymic involution and circulating thymic hormone activity. J Clin Endocr Metab 1978;47:145\u2013150","journal-title":"J Clin Endocr Metab"},{"key":"BF02786456_CR37","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0140-6736(77)91601-4","volume":"2","author":"V Lewis","year":"1977","unstructured":"Lewis V, Twomey JJ, Goldstein G, O\u2019Reilly R, Smithwick E, Pahwa R, Pahwa S, Good RA, Schulte-Wisserman H, Horowitz S, Hong R, Jones J, Sieber O, Kirkpatrick C, Polmar S, Bealmear P: Circulating thymic-hormone activity in congenital immunodeficiency. Lancet 1977;2:471\u2013475.","journal-title":"Lancet"},{"key":"BF02786456_CR38","first-page":"311","volume":"34","author":"CH Kirkpatrick","year":"1978","unstructured":"Kirkpatrick CH, Greenberg LE, Chapman SW, Goldstein G, Lewis VM, Twomey JJ: Plasma thymic hormone activity in patients with chronic mucocutaneous candidiasis. Clin Exp Immunol 1978; 34:311\u2013317.","journal-title":"Clin Exp Immunol"},{"key":"BF02786456_CR39","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/S0140-6736(66)90479-X","volume":"2","author":"G Goldstein","year":"1966","unstructured":"Goldstein G: Thymitis and myasthenia gravis. Lancet 1966; 2:1164\u20131167.","journal-title":"Lancet"},{"key":"BF02786456_CR40","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0140-6736(66)92599-2","volume":"2","author":"G Goldstein","year":"1966","unstructured":"Goldstein G, Whittingham S: Experimental autoimmune thymitis. An animal model of human myasthenia gravis. Lancet 1966; 2:315\u2013318.","journal-title":"Lancet"},{"key":"BF02786456_CR41","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/249863d0","volume":"249","author":"G Goldstein","year":"1974","unstructured":"Goldstein G: Reply to bovine thymin. Nature 1974;249:863\u2013864.","journal-title":"Nature"},{"key":"BF02786456_CR42","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1126\/science.180600","volume":"193","author":"A Brand","year":"1976","unstructured":"Brand A, Gilmour DG, Goldstein G: Lymphocyte-differentiating hormone of Bursa Fabricius. Science 1976; 193:319\u2013321.","journal-title":"Science"},{"key":"BF02786456_CR43","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1749-6632.1975.tb29102.x","volume":"249","author":"MP Scheid","year":"1975","unstructured":"Scheid MP, Goldstein G, Hammerling U, Boyse EA: Lymphocyte differentiation from precursor cells in vitro. Ann N Y Acad Sci 1975; 249:531\u2013540.","journal-title":"Ann N Y Acad Sci"},{"issue":"S","key":"BF02786456_CR44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02919050","volume":"4","author":"G Goldstein","year":"1985","unstructured":"Goldstein G, Audhya TK: Thymopoietin and thymopentin: Experimental studies. Surv Immunol Res 1985;4(S)1:1\u201310.","journal-title":"Surv Immunol Res"},{"key":"BF02786456_CR45","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.4049\/jimmunol.120.5.1594","volume":"120","author":"GH Sunshine","year":"1978","unstructured":"Sunshine GH, Basch RS, Coffey RG, Cohen KW, Goldstein G, Hadden JW: Thymopoietin enhances the allogeneicresponseandcyclic GMP levels of mouse peripheral, thymus derived lymphocytes. J Immunol 1978;120:1594\u20131599.","journal-title":"J Immunol"},{"key":"BF02786456_CR46","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0003-9861(84)90338-2","volume":"234","author":"T Audhya","year":"1984","unstructured":"Audhya T, Talle MA, Goldstein G: Thymopoietin radioreceptor assay utilizing lectin-purified glycoprotein from a biologically responsive T cell line. Archs Biochem Biophys 1984;234:167\u2013177.","journal-title":"Archs Biochem Biophys"},{"key":"BF02786456_CR47","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1399-3011.1994.tb00574.x","volume":"44","author":"DD Smith","year":"1994","unstructured":"Smith DD, Conlon JM, Petzel J, Chen L, Murphy RF, Morley BJ: Solid phase peptide synthesis and biological activity of bovine thymopoietin II (TP-II) Int J. Pept Protein Res 1994;44:183\u2013191.","journal-title":"Pept Protein Res"},{"key":"BF02786456_CR48","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/0968-0896(95)00121-V","volume":"3","author":"T Abiko","year":"1995","unstructured":"Abiko T, Sekino H: Synthesis of [Phe(4F)3] thymopoietin II and examination of its immunological effect of the impaired blastogenic response of T lymphocytes of uremic patients. Bioorg Med Chem 1995; 3:1369\u20131375.","journal-title":"Bioorg Med Chem"},{"key":"BF02786456_CR49","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0140-6736(75)90966-6","volume":"2","author":"G Goldstein","year":"1975","unstructured":"Goldstein G, Schlesinger DH: Thymopoietin and myasthenia gravis: neostigmine-responsive neuromuscular block produced in mice by a synthetic peptide fragment of thymopoietin. Lancet 1975;2:256\u2013259.","journal-title":"Lancet"},{"key":"BF02786456_CR50","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1126\/science.190.4220.1211","volume":"190","author":"MP Scheid","year":"1975","unstructured":"Scheid MP, Goldstein G, Boyse EA: Differentiation of T cells in nude mice. Science 1975;190:1211\u20131213.","journal-title":"Science"},{"key":"BF02786456_CR51","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1084\/jem.156.4.1057","volume":"156","author":"GE Ranges","year":"1982","unstructured":"Ranges GE, Goldstein G, Boyse EA, Scheid MP: T cell development in normal and thymopentin treated nude mice. J Exp Med 1982;156:1057\u20131064.","journal-title":"J Exp Med"},{"key":"BF02786456_CR52","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/0003-9861(82)90525-2","volume":"217","author":"JB Vaughn","year":"1982","unstructured":"Vaughn JB Jr, Stephens RL, Lenkinski RE, Heavner GA, Goldstein G, Rama Krishna N: Nuclear magnetic resonance analysis of Gd3+-induced perturbation in thymopoietin32-36. A study of amide and aromatic proton resonances. Arch Biochem Biophys 1982;217:468\u2013472.","journal-title":"Arch Biochem Biophys"},{"key":"BF02786456_CR53","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1399-3011.1979.tb01959.x","volume":"14","author":"JP Tischio","year":"1979","unstructured":"Tischio JP, Patrick JE, Weintraub HS, Chasin M, Goldstein G: Short in vivo half life of thymopoietin 32\u201336 pentapeptide in human plasma. Intl J Peptide Res 1979; 14:479\u2013484.","journal-title":"Intl J Peptide Res"},{"key":"BF02786456_CR54","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0167-5699(83)90028-2","volume":"4","author":"J Duchateau","year":"1983","unstructured":"Duchateau J, Delespesse G, Bolla K: Phase variation in the modulation of the human immune response. Immunol Today 1983; 4:213\u2013214","journal-title":"Immunol Today"},{"key":"BF02786456_CR55","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1399-3011.1984.tb02696.x","volume":"23","author":"D Tourwe","year":"1984","unstructured":"Tourwe D, Deloen, JL, Hallenga K, Van Bisnt G: Conformational properties of the pentapeptide fragment (32\u201336) of the thymic hormone thymopoietin. Int J Peptide Protein Res 1984;23:84\u201393.","journal-title":"Int J Peptide Protein Res"},{"key":"BF02786456_CR56","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-9861(85)90499-0","volume":"242","author":"GA Heavner","year":"1985","unstructured":"Heavner GA, Audhya T, Kroon D, Goldstein G: Structural requirement for the biological activity of thymopentin analogs. Arch Biochem Biophys 1985; 242: 248\u2013255.","journal-title":"Arch Biochem Biophys"},{"key":"BF02786456_CR57","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF02985219","volume":"6","author":"J Duchateau","year":"1989","unstructured":"Duchateau J, Bolla K: Immunomodulation with TP-5: In vitro studies. Med Oncol Tumor Pharmacother 1989;6:19\u201323.","journal-title":"Med Oncol Tumor Pharmacother"},{"key":"BF02786456_CR58","first-page":"195","volume":"20","author":"HJ Wedner","year":"1976","unstructured":"Wedner HJ, Parker CW: Lymphocyte activation. Prog Allergy 1976;20:195\u2013300.","journal-title":"Prog Allergy"},{"issue":"S","key":"BF02786456_CR59","first-page":"16","volume":"4","author":"J Duchateau","year":"1985","unstructured":"Duchateau J, Servais G, Cooman R, Collet H, Bolla K: In vitro influence of thymopentin on proliferative responses and phytohaemagglutinin-induced IL 2 production in normal human lymphocyte cultures. Surv Immunol Res 1985;4 (S)1:1 16\u2013124.","journal-title":"Surv Immunol Res"},{"key":"BF02786456_CR60","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0192-0561(90)90053-P","volume":"12","author":"C Hu","year":"1990","unstructured":"Hu C, Radelli L, Scorza R, Bonara P, Perego R, Fantuzzi G: In vivo enhancement of NK cell activity by thymopentin. Int J Immunopharmacol 1990; 12:193\u2013197.","journal-title":"Int J Immunopharmacol"},{"key":"BF02786456_CR61","first-page":"375","volume":"5","author":"M Fiorilli","year":"1983","unstructured":"Fiorilli M, Sirianni MC, Sorrentino R, Testi U, Aiuti F: In vitro enhancement of bone marrow natural killer cells after incubation with Thymopoietin32-36 (TP-5). Thymus 1983;5:375\u2013382.","journal-title":"Thymus"},{"key":"BF02786456_CR62","first-page":"362","volume":"76","author":"E Cillari","year":"1992","unstructured":"Cillari E, Milano S, Dieli M, Arcoleo F, Perego R, Leoni F, Gromo G, Severn A, Liew, FY: Thymopentin reduces susceptibility of aged mice to cutaneous leishmaniasis by modulating CD4 T cell subsets. Immunology 1992; 76:362\u2013366.","journal-title":"Immunology"},{"key":"BF02786456_CR63","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/BF01990958","volume":"35","author":"R Brauer","year":"1992","unstructured":"Brauer R, Thoss K, Henzgen S, Waldmann G: Effects of immunomodulator diacetylsplenopentin on antigen induced arthritis in rabbits. Agents Action 1992; 35:96\u2013103.","journal-title":"Agents Action"},{"key":"BF02786456_CR64","doi-asserted-by":"crossref","first-page":"C95","DOI":"10.1007\/BF01991149","volume":"38","author":"R Brauer","year":"1993","unstructured":"Brauer R, Egg AJ, Henzgen S, Kriegsmann J, Thoss K: The effect of immunomodulatory thymic and splenic peptides and cyclosporin-A on antigen induced arthritis in rats. Agents Action 1993;38:C95-C97.","journal-title":"Agents Action"},{"key":"BF02786456_CR65","first-page":"866","volume":"44","author":"E Sundal","year":"1994","unstructured":"Sundal E, Bertelletti D: Management of viral infections with thymopentin. Arzneimittelforschung 1994;44:866\u2013871.","journal-title":"Arzneimittelforschung"},{"key":"BF02786456_CR66","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1365-3083.1994.tb03503.x","volume":"40","author":"F Nicoletti","year":"1994","unstructured":"Nicoletti F, Zaccone P, Magro G, Barcellini W, Cavallaro V, Belli G, Concuzza C, Di Marco R, Meroni PL: The effects of thymopentin on the development of SLE like syndrome in the MRL\/lpr-lpr mouse. Scan J Immunol 1994; 40:549\u2013556.","journal-title":"Scan J Immunol"},{"key":"BF02786456_CR67","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0192-0561(94)90138-4","volume":"16","author":"M Mattei","year":"1994","unstructured":"Mattei M, Bach S, Di-Cesare S, Fraziano M, Placido R, Poccia F, Sammarco I, Moras AM, Bardone MR, Colizzi V: CD4-8-T cells increase in MRL\/lpr mice treated with thymic factors. Int J Immunopharmacol 1994; 16:651\u2013658.","journal-title":"Int J Immunopharmacol"},{"key":"BF02786456_CR68","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF00665692","volume":"27","author":"F Gallo","year":"1993","unstructured":"Gallo F, Morale MC, Sambataro D, Farinella Z, Scapagnini U., Marchetti B: The immune system response during development and progression of carcinogen induced rat mammary tumors: prevention of tumor growth and restoration of immune system responsiveness by thymopentin. Breast Cancer Res Treat 1993;27:221\u2013237.","journal-title":"Breast Cancer Res Treat"},{"key":"BF02786456_CR69","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/00002371-199302000-00003","volume":"13","author":"DD Taylor","year":"1993","unstructured":"Taylor DD, Gercel-Taylor C, Fowler WC, Weese JL: Enhancement of antitumor effects of combined chemoimmunotherapy. J Immunother 1993; 13:91\u201397.","journal-title":"J Immunother"},{"key":"BF02786456_CR70","first-page":"245","volume":"58","author":"VK Ghanta","year":"1991","unstructured":"Ghanta VK, Hiramoto NS, Soong SJ, Hiramoto RN: Effect of thymic hormone treatment on several immune functions of nude mice. MechAgeingDev 1991;58:245\u2013254.","journal-title":"MechAgeingDev"},{"key":"BF02786456_CR71","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1600-0773.1993.tb01646.x","volume":"72","author":"N Barbera","year":"1993","unstructured":"Barbera N, Palmicci T, Chiarenza A, Bartoloni G, Cordaro S, Greco S, Scapagnini U, Bernardini R: Radioprotective effects of the association thymopentin-interleukin-l\u03b1 in the C57BL\/6 mouse. Pharmacol Toxicol 1993;72:256\u2013261.","journal-title":"Pharmacol Toxicol"},{"key":"BF02786456_CR72","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/0192-0561(93)90005-J","volume":"15","author":"G Ravagnan","year":"1993","unstructured":"Ravagnan G, Falchetti R, Lanzilli G, Di Francesco P, Gaziano R, Favalli C, Garaci E: Effect of synthetic thymic hormones on the cocaine-induced inhibition of primary immune response in mice. Int J Immunopharmacol 1993; 15: 879\u2013885.","journal-title":"Int J Immunopharmacol"},{"key":"BF02786456_CR73","first-page":"345","volume":"160","author":"M Braga","year":"1994","unstructured":"Braga M, Di Franscesco A, Gianotti L, Vignalli A, Costantini E, Socci C, Fortis C, Paganelli G, Di Carlo V: Thymopentin increases the survival of mice after allogeneic blood transfusion, bacterial gavage, and burn injury. Eur J Surg 1994; 160:345\u2013350.","journal-title":"Eur J Surg"},{"key":"BF02786456_CR74","first-page":"697","volume":"113","author":"P Mallmann","year":"1991","unstructured":"Mallmann P, Krebs D: The effect of adjuvant combined chemo\/ immunotherapy on immunological parameters and clinical course in patients with breast carcinoma. Zentralbl Gynakol 1991 ;113:697\u2013706.","journal-title":"Zentralbl Gynakol"},{"key":"BF02786456_CR75","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/030089169508100110","volume":"81","author":"L Lauro Di","year":"1995","unstructured":"Di Lauro L, Del Medico P, Carpano S, Cancrini A, Gionfra T, Vici P, Roselli M, Lopez M: Sequential sub-cutaneous thymopentin, interferon \u03b12a and interleukin-2 in metastatic renal cancer. Tumori 1995;81:42\u201344.","journal-title":"Tumori"},{"key":"BF02786456_CR76","first-page":"611","volume":"14","author":"A Denaro","year":"1994","unstructured":"Denaro A, Stivala F, Mazzarino MC: Immunologic study on patients with head and neck cancer treated with thymopentin associated with surgery, chemotherapy, radiotherapy. Acta Otorhinolaryngol Ital 1994; 14:611\u2013625.","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"BF02786456_CR77","first-page":"457","volume":"146","author":"T Maurizio","year":"1995","unstructured":"Maurizio T, Belli G, Santarelli M, Raffetto N, Margherita T: Valutazione del trattamento con timopentina associato alla radiotgerapia nei tumori della testa e del collo. Clin Ter 1995;146:457\u2013467.","journal-title":"Clin Ter"},{"key":"BF02786456_CR78","first-page":"1101","volume":"49","author":"A Sortini","year":"1994","unstructured":"Sortini A, Di Marco L, Navarra G, Donini A, Fiorentini G, Santini M, Sartori A, Donini I: Treatment with immunomodulating drugs of patients with operated cancer. Minerva Chir 1994;49:1101\u20131105.","journal-title":"Minerva Chir"},{"key":"BF02786456_CR79","first-page":"731","volume":"14","author":"R Gebbia","year":"1994","unstructured":"Gebbia R, Valenza A, Testa G, Borsellino CN, Gebbia N: A prospective randomized trial of thymopentin versus granulocytecolony stimulating factor with or without thymopentin in the prevention of febrile episodes in cancer patients undergoing highly cytotoxic chemotherapy. Anticancer Res 1994;14:731\u2013734.","journal-title":"Anticancer Res"},{"key":"BF02786456_CR80","first-page":"91","volume":"i","author":"BusincoL AiutiF","year":"1980","unstructured":"AiutiF, BusincoL, Rossi P, Quinti I: Response to thymopoietin pentapeptide in a patient with DiGeorge Syndrome. Lancet 1980;i:91.","journal-title":"Lancet"},{"key":"BF02786456_CR81","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0140-6736(83)92810-6","volume":"i","author":"F Aiuti","year":"1983","unstructured":"Aiuti F, Fierily M, Quinti I, Seminara R, Businco L, Galli E, Rossi P, Goldstein G: Thymopoietin pentapeptide treatment of primary immunodeficiencies. Lancet 1983;i:551\u2013554.","journal-title":"Lancet"},{"key":"BF02786456_CR82","first-page":"69","volume":"8","author":"MI Joffe","year":"1982","unstructured":"Joffe MI, Sochett E, Pettifor JM, Rabson AR: A case of DiGeorge syndrome treated with thymopoietin pentapeptide (TP-5) demonstrating an adherent suppressor cell of lymphocyte function. J Clin Lab Immunol 1982;8:69\u201373.","journal-title":"J Clin Lab Immunol"},{"key":"BF02786456_CR83","first-page":"344","volume":"45","author":"M Fiorilli","year":"1981","unstructured":"Fiorilli, M, Sirianni MC, Pandolfi F, Quinti I, Tosti U, Aiuti F, Goldstein G: Improvement of NK activity of T cells after thymopoietin pentapeptide therapy in a patient with severe combined immunodeficiency. Clin Exp Immunol 1981 ;45:344\u2013351.","journal-title":"Clin Exp Immunol"},{"issue":"S","key":"BF02786456_CR84","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/BF02919063","volume":"4","author":"J Duchateau","year":"1985","unstructured":"Duchateau J, Servais G, Vreyers R, Delespesse G, Bolla K: Modulation of immune response in aged humans through different administration modes of thymopentin. Surv Immun Res 1985;4 (S):94\u2013101.","journal-title":"Surv Immun Res"},{"key":"BF02786456_CR85","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.4049\/jimmunol.130.4.1970","volume":"130","author":"W Domzig","year":"1983","unstructured":"Domzig W, Stadler BM, Herberman RB: Interleukin 2 dependence of human natural killer (NK)cell activity. J Immunol 1983;130:1970\u20131973.","journal-title":"J Immunol"},{"key":"BF02786456_CR86","first-page":"152","volume":"101","author":"RC Williams","year":"1983","unstructured":"Williams RC, Montano JD, Bankhurs AD: Abrogation of in vitro suppressor cell activity in adult common variable hypogammaglobulinamia after TP-5 treatment. J Lab Clin Med 1983;101:152\u2013160.","journal-title":"J Lab Clin Med"},{"key":"BF02786456_CR87","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1136\/adc.67.9.1095","volume":"67","author":"KH Hsieh","year":"1992","unstructured":"Hsieh KH, Shaio, MF, Liao, TN: Thymopentin treatment in severe atopic dermatitis\u2014clinical and immunological evaluations. Arch Dis Child 1992;67:1095\u20131002.","journal-title":"Arch Dis Child"},{"key":"BF02786456_CR88","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000233177","volume":"69","author":"IL Strannegard","year":"1982","unstructured":"Strannegard IL, Kang K, Cooper KD, Hanifen JM: FcIgG receptorbearing lymphocytes and monoclonal antibody-defined subsets in atopic dermatitis: Effect of treatment with thymopoietin pentapeptide (TP-5). Intl Arch Allergy Appl Immunol 1982;69:238\u2013244.","journal-title":"Intl Arch Allergy Appl Immunol"},{"key":"BF02786456_CR89","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0190-9622(83)70042-3","volume":"8","author":"K Kang","year":"1983","unstructured":"Kang K, Cooper KD, Hanifen JM: Thymopoietin pentapeptide (TP-5) improves clinical parameters and lymphocyte sub-populations in atopic dermatitis. J Am Acad Dermatol 1983;8:372\u2013377.","journal-title":"J Am Acad Dermatol"},{"key":"BF02786456_CR90","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0190-9622(94)70068-0","volume":"30","author":"MJ Stiller","year":"1994","unstructured":"Stiller MJ, Shupack JL, Kenny C, Jondreau L, Cohen DE, Soter NA: A double blind, placebo-controlled clinical trial to evaluate the safety and efficacy of thymopentin as an adjunctive treatment in atopic dermatitis. J Am Acad Dermatol1994;30:597\u2013602.","journal-title":"J Am Acad Dermatol"},{"key":"BF02786456_CR91","first-page":"543","volume":"11","author":"KD Cooper","year":"1993","unstructured":"Cooper KD: New theraupeutic approaches in atopic dermatitis. Clin Rev Allergy 1993; 11:543\u2013559.","journal-title":"Clin Rev Allergy"},{"key":"BF02786456_CR92","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/1523-1747.ep12371746","volume":"102","author":"KD Cooper","year":"1994","unstructured":"Cooper KD: Atopic dermatitis: recent trends in pathogenesis and therapy. J Invest Dermatol 1994; 102:128\u2013137.","journal-title":"J Invest Dermatol"},{"key":"BF02786456_CR93","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3109\/08923978009026413","volume":"2","author":"T Perri Di","year":"1980","unstructured":"Di Perri T, Laghi-Pasini F, Auteri A: Immunokinetics of a single dose of thymopoietin pentapeptide. J. Immunopharmacol. 1980;2:567\u2013572.","journal-title":"J. Immunopharmacol."},{"key":"BF02786456_CR94","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/rheumatology\/21.2.72","volume":"21","author":"PA Thrower","year":"1982","unstructured":"Thrower PA, Doyle DV, Scott J, Huskisson EC: Thymopoietin in rheumatoid arthritis. Rheumatol Rehabl 1982;21:72\u201377.","journal-title":"Rheumatol Rehabl"},{"key":"BF02786456_CR95","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1248\/cpb.29.2322","volume":"29","author":"T Abiko","year":"1981","unstructured":"Abiko T, Onodera I, Sekino H: Effects of thymopoietin II fragments on E-rosette forming cells of rheumatoid arthritis patients. Chem Pharm Bull 1981;29:2322\u20132329.","journal-title":"Chem Pharm Bull"},{"key":"BF02786456_CR96","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0192-0561(81)90025-4","volume":"3","author":"EM Veys","year":"1981","unstructured":"Veys EM, Hermanns P, Goldstein G, Kung, P, Schiinder J, Van Wauwe J: Determination of T lymphocyte sub-population by monoclonal antibodies in rheumatoid arthritis. Influence of immunomodulating agents. J Immunopharmacol 1981;3:313\u2013319.","journal-title":"J Immunopharmacol"},{"key":"BF02786456_CR97","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/ard.41.5.441","volume":"41","author":"EM Veys","year":"1982","unstructured":"Veys EM, Huskisson EC, Rosenthal M, Vischer TL, Mielants H, Thrower PA, Scott J, Ott H, Scheijgrond H, Symdens J: Clinical response to therapy with thymopoietin pentapeptide (TP-5) in rheumatoid arthritis. Anna Rheum Dis 1982;41: 441\u2013443.","journal-title":"Anna Rheum Dis"},{"key":"BF02786456_CR98","first-page":"71","volume":"5","author":"A Afeltra","year":"1991","unstructured":"Afeltra A, Galeazzi M, Basso P, Pietrucci A, De-Pita O, Ferri GM, Porzio F, Bonomo L: Immune imbalance in synovial fluid of rheumatoid arthritis patients: effects of intra-articular injection of thymopentin. J Biol Reg Homeost Agents 1991;5:71\u201375.","journal-title":"J Biol Reg Homeost Agents"},{"key":"BF02786456_CR99","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1749-6632.1992.tb24663.x","volume":"651","author":"F Ambrogi","year":"1992","unstructured":"Ambrogi F, Ricciardi L, Nutini P, Vanacore P: CD5+ B lymphocytes and T cell subsets in a case of juvenile rheumatoid arthritis. Ann NY Acad Sci 1992;651:564\u2013569.","journal-title":"Ann NY Acad Sci"},{"key":"BF02786456_CR100","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1185\/03007999409110483","volume":"13","author":"C Danese","year":"1994","unstructured":"Danese C, Zavattaro E, Calisi L, Marciano F, Perego MA: Long term thymopentin treatment in systemic scleroderma. Curr Med Res Opin 1994;13:195\u2013201.","journal-title":"Curr Med Res Opin"},{"key":"BF02786456_CR101","first-page":"227","volume":"86","author":"A Borromei","year":"1995","unstructured":"Borromei A, Draghetti M, Guerra L, Lozito A, Vargiu B: Multiple Sclerosis. Presentation of a case treated with thymopentin. Minerva Med 1995;86:227\u2013232.","journal-title":"Minerva Med"},{"key":"BF02786456_CR102","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0168-8278(05)80314-9","volume":"21","author":"G Fattovich","year":"1994","unstructured":"Fattovich G, Giustina G, Alberti A, Guido M, Pontisso P, Favarato S, Benvegnu L, Ruol A: A randomized controlled trial of thymopentin therapy in patients with chronic hepatitis B. J Hepat 1994:21:361\u2013366.","journal-title":"J Hepat"},{"key":"BF02786456_CR103","first-page":"505","volume":"45","author":"PA Tovo","year":"1993","unstructured":"Tovo PA, De Martino M, Rossi P, Cavagni, G, Masi M, Bardare M: The use of thymopentin in the prevention of recurrent infections of the respiratory system. Multicentre study. Minerva Pediatr 1993;45:505\u2013510.","journal-title":"Minerva Pediatr"},{"key":"BF02786456_CR104","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1742-1241.1993.tb09664.x","volume":"47","author":"E Sundal","year":"1993","unstructured":"Sundal E: Thymopentin prophylactic treatment in patients with recurrent respiratory infections. Br J Clin Pract 1993;47:198\u2013204.","journal-title":"Br J Clin Pract"},{"key":"BF02786456_CR105","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/00002030-199211000-00016","volume":"6","author":"MA Conant","year":"1992","unstructured":"Conant MA, Calabrese LH, Thompson SE, Poiesz BJ, Rasheed S, Hirsch RL, Meyerson LA, Kremer AB, Wang CC, Goldstein G: Maintenance of CD4+ cells by thymopentin in asymptomatic HIV-infected subjects: results of double blind placebo controlled study. AIDS 1992;6:1335\u20131339.","journal-title":"AIDS"},{"key":"BF02786456_CR106","first-page":"279","volume":"8","author":"G Goldstein","year":"1995","unstructured":"Goldstein G, Conant MA, Beall G, Grossman HA, Galpin JE, Blick G, Calabrese LH, Hirsh RL, Fisher A, Stampone P, Meyerson LA: Safety and efficacy of thymopentin in zidovudine (AZT) treated asymptomatic HIV infected subjects with 200\u2013500 CD4 cells\/mm3: a double blind placebo controlled trial. J AIDS Hum Retrovirol 1995;8:279\u2013288.","journal-title":"J AIDS Hum Retrovirol"},{"key":"BF02786456_CR107","first-page":"351","volume":"19","author":"S Coppola","year":"1996","unstructured":"Coppola S, Buccoliero G, Laddago V, Monno L, Perrone A, Guida G, Schiraldi O, Angarano G: Topical thymopentin therapy in HIV positive patients with recurrent oral candidiasis: A pilot study. Microbiologica 1996:19:351\u2013356.","journal-title":"Microbiologica"},{"key":"BF02786456_CR108","first-page":"255","volume":"47","author":"GL Grismondi","year":"1995","unstructured":"Grismondi GL, Marini A: Thymopentin and cervico vaginal HPV infections associated with cervical intraepithelial neoplasia (CIN). Minerva Ginecol 1995;47:255\u2013257.","journal-title":"Minerva Ginecol"},{"key":"BF02786456_CR109","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0022-5223(19)33842-5","volume":"105","author":"A Markewitz","year":"1993","unstructured":"Markewitz A, Faist E, Lang S, Endres S, Fuchs D, Reichart B: Successful restoration of cell mediated immune response after cardiopulmonary by pass by immunomodulation. Thorac Cardiovasc Surg 1993; 105:15\u201324.","journal-title":"Thorac Cardiovasc Surg"},{"key":"BF02786456_CR110","first-page":"253","volume":"16","author":"R Vecchio","year":"1995","unstructured":"Vecchio R, Ferrara M, Mosca F, Messina G, Ignoto A, Di Martino M, Latteri F: Thymopentin in the prevention of post-splenectomy infections. Giorri Chir 1995;16: 253\u2013255.","journal-title":"Giorri Chir"},{"key":"BF02786456_CR111","first-page":"427","volume":"60","author":"C Launo","year":"1994","unstructured":"Launo C, De Grandi R, Augeri C, Palermo S, Cammardella MP, Mauro E, Doveri A, Maio M, Mantelli C: Changes in immune status due to anaesthesia and surgical interventions. The role of thymopentin and interleukin. Minerva Anesthesiol 1994;60: 427\u2013435.","journal-title":"Minerva Anesthesiol"},{"key":"BF02786456_CR112","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/0090-1229(83)90119-8","volume":"26","author":"J Thivolet","year":"1983","unstructured":"Thivolet J, Faure M, Nicolas JF, Maudiut G, Claudy A: Therapeutic use of TP-5 (thymopoietin 32\u201336) in sarcoidosis of the skin. Clin Immunol Immunopathol 1983; 26:350\u2013360.","journal-title":"Clin Immunol Immunopathol"},{"key":"BF02786456_CR113","first-page":"327","volume":"86","author":"M Botturi","year":"1993","unstructured":"Botturi M, Panzarasa R, Agostara B, Armarolli L, Belli M Barone D, Boccone F, Busutti L, Catalano E, Ciambellotti E: Effects of immunomodulation on antineoplastic radiotherapy. A controlled clinical study. Radiol Med 1993;86: 327\u2013335.","journal-title":"Radiol Med"},{"key":"BF02786456_CR114","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000213656","volume":"41","author":"R Bisselli","year":"1995","unstructured":"Bisselli R, Fagiolo U, Nisini R, Paganelli R, D\u2019offizi G, Ferrara R, Bertollo L, D\u2019 Amelio R: Humoral response to influenza hemagglutinin: Oligoclonal spectrotype and failure of thymopentin as immunoadjuvant. Gerontology 1995:41:3\u201310.","journal-title":"Gerontology"},{"key":"BF02786456_CR115","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3109\/10428199509049773","volume":"16","author":"A Venditti","year":"1995","unstructured":"Venditti A, Scimo MT, Poeta GD, Buccisano F, Stasi R, Mastino A, Grelli S, Favalli C, Garaci E, Papa G: Recombinant interferon-(2a, thymopentin and low doses of cytosine arabinoside for the treatment of myelodysplastic syndromes. A pilot study. Leukemia Lymphoma 1995; 16: 335\u2013342.","journal-title":"Leukemia Lymphoma"},{"key":"BF02786456_CR116","first-page":"96","volume":"40","author":"EM Vazhnychaya","year":"1994","unstructured":"Vazhnychaya EM, Tarasenko LM, Deviatkina TO: Effect of thymopentin on non-specific resistance in chronic stress. Fiziol Zh 1994;40:96\u201399.","journal-title":"Fiziol Zh"},{"key":"BF02786456_CR117","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/1523-1747.ep12517686","volume":"81","author":"AC Chu","year":"1983","unstructured":"Chu AC, Patterson JAK, Goldstein G, Berger CL, Takezaki S, Edelson RL: Thymopoietin-like substance in human skin. J Invest Derm. 1983;81:194\u2013197.","journal-title":"J Invest Derm."},{"key":"BF02786456_CR118","first-page":"20","volume":"40","author":"BV Oliinyk","year":"1994","unstructured":"Oliinyk BV, Sydorenko OV, Bohdanovych LV: Natural factor of splenin and mechanisms of its action. Fiziol Zh 1994:40:20\u201326.","journal-title":"Fiziol Zh"},{"key":"BF02786456_CR119","first-page":"100","volume":"40","author":"BV Oliinyk","year":"1994","unstructured":"Oliinyk BV, Bogdanovych LV, Zhuravskyi MH: Role of nonprotein factor of splenin in the regulation of antibody formation. Fiziol Zh 1994:40:100\u2013105.","journal-title":"Fiziol Zh"},{"key":"BF02786456_CR120","first-page":"46","volume":"7","author":"VA Kikot","year":"1989","unstructured":"Kikot VA, Dziubko NI: Nonspecific active stimulation of the immune system in the combined treatment of rectal cancer. Vrach Delo 1989;7:46\u201348.","journal-title":"Vrach Delo"},{"key":"BF02786456_CR121","first-page":"90","volume":"4","author":"VM Frolov","year":"1992","unstructured":"Frolov VM, Peresadin NA, Dekaliuk IV, Pshenichnyi II: The tocopherol acetate and splenin correction of the immunological disorders in patients with viral hepatitis B. Lik Sprava 1992;4:90\u201391.","journal-title":"Lik Sprava"},{"key":"BF02786456_CR122","first-page":"70","volume":"5-6","author":"VM Frolov","year":"1993","unstructured":"Frolov VM, Peresadin NA, Vysotskii I, Tischenko AN, Pinskii LL: The immunomodulatory effect of vilozen and splenin in the treatment of patients with acute and chronic toxic allergic hepatitis. Lik Sprava 1993;5-6:70\u201372.","journal-title":"Lik Sprava"},{"key":"BF02786456_CR123","first-page":"79","volume":"8","author":"VM Frolov","year":"1992","unstructured":"Frolov VM, Peresadin NA, Ershova IB, Demenkov VR, Miankina AV: The immunomodulating action of vilozen and splenin in angina patients against a background of chronic bronchitis. Lik Sprava 1992;8:79\u201381.","journal-title":"Lik Sprava"},{"key":"BF02786456_CR124","first-page":"30","volume":"5-6","author":"VM Frolov","year":"1992","unstructured":"Frolov VM, Peresadin NA, Pustovoi I: Combined chemotherapy of toxic hepatitis in patients with pulmonary tuberculosis. Probl Tuberk 1992;5-6:30\u201331.","journal-title":"Probl Tuberk"},{"key":"BF02786456_CR125","first-page":"97","volume":"1","author":"NM Bereza","year":"1992","unstructured":"Bereza NM, Selezneva SI, Mosalova NM, Boiko TI, Cherniakova VI, Shevtsova ZI, Kudriavtseva V: Enterobsorption in the treatment of ulcerative colitis patients. Lik Sprava 1992; 1:97\u2013100.","journal-title":"Lik Sprava"},{"key":"BF02786456_CR126","first-page":"39","volume":"65","author":"AV Epishin","year":"1993","unstructured":"Epishin AV, Khabarova NA, Grytsiv VY, Venger YP: Idiopathic hypothyroidism. Combined treatment with immnomodifying drugs. Terapevt Arkh 1993;65: 39\u201342.","journal-title":"Terapevt Arkh"},{"key":"BF02786456_CR127","first-page":"453","volume":"15","author":"OL Isakova","year":"1989","unstructured":"Isakova OL, Sepetov NF, Forner K, Erlich A: Enzymatic hydrolysis of splenopentin and its analogs in human serum. Bioorg Khim 1989; 15:453\u2013459.","journal-title":"Bioorg Khim"},{"key":"BF02786456_CR128","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0014-5793(93)81498-O","volume":"17","author":"A Rastogi","year":"1993","unstructured":"Rastogi A, Singh VK, Biswas S, Haq W, Mathur KB, Agarwal SS: Augmentation of human natural killer cells by splenopentin analogs. FEBS Lett 1993;17:93\u201395.","journal-title":"FEBS Lett"},{"key":"BF02786456_CR129","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0192-0561(85)90298-X","volume":"7","author":"Y Legarrec","year":"1985","unstructured":"Legarrec Y, Morin A, Chedid L: Modifications of natural killer activity in the mouse by MDP and various muramyl peptides relationship with adjuvant or infectious properties. Int J Immmunopharmacol 1985;7:343.","journal-title":"Int J Immmunopharmacol"},{"key":"BF02786456_CR130","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0024-3205(84)90151-6","volume":"35","author":"N Kay","year":"1984","unstructured":"Kay N, Allen J, Morley JE: Endorphins stimulate normal human peripheral blood lymphocyte natural killer activity. Life Sci 1984;35:53\u201359.","journal-title":"Life Sci"},{"key":"BF02786456_CR131","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0192-0561(94)00080-8","volume":"17","author":"K Bajpai","year":"1995","unstructured":"Bajpai K, Singh VK, Agarwal SS, Dhawan VC, Naqvi T, Haq W, Mathur KB: Immunomodulatory activity of met-enkephalin and its two potent analogs. Int. J. Immunopharmacol. 1995; 17:207\u2013212.","journal-title":"Int. J. Immunopharmacol"},{"key":"BF02786456_CR132","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0008-8749(81)90303-8","volume":"62","author":"SD Sharma","year":"1981","unstructured":"Sharma SD, Tsac V, Krahenbuhl JL, Lemington JS: Augmentation of mouse natural killer cellactivity by muramyldipeptide and its analogs. Cell Immunol 1981; 62:101\u2013109.","journal-title":"Cell Immunol"},{"key":"BF02786456_CR133","first-page":"521","volume":"41","author":"M Chatterjee-Kishore","year":"1997","unstructured":"Chatterjee-Kishore M, Agrawal S, Singh VK, Mathur KB, Agarwal SS: Up regulation of HLA class-I gene transcription in K562 cells by analogs of splenopentin (SP-5). Biochem Mol Biol Intl 1997; 41:521\u2013528.","journal-title":"Biochem Mol Biol Intl"},{"key":"BF02786456_CR134","unstructured":"Biswas S, Singh VK, Rastogi A, Sharan R, Hag W, Mathur KB, Agarwal SS: Stimulation of IL-2 production and CD2R expression by splenopentin analogs. Int J Immunopharmacol, in press."},{"key":"BF02786456_CR135","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/0192-0561(90)90040-T","volume":"12","author":"HA Weber","year":"1990","unstructured":"Weber HA, Maciejewski J, Eckert R, Schutt M, Deizel W, Volk, HD: Splenopentin (DAc SP-5) accelerates the restoration of myelopoietic and immune systems after sublethal radiation in mice. Int J Immunopharmacol 1990;12:761\u2013768.","journal-title":"Int J Immunopharmacol"},{"key":"BF02786456_CR136","first-page":"267","volume":"37","author":"R Eckert","year":"1986","unstructured":"Eckert R, Diezel W, Forner K, Pfuller V, Sonnichsen N, Von Baehr R: Histamine receptor bearing lymphocytes (HRL). VIII. Splenopentin accelerated reconstitution of the immunoresponsive after elimination of HRL. Allerg Immun 1986;37:267\u2013272.","journal-title":"Allerg Immun"},{"key":"BF02786456_CR137","first-page":"161","volume":"59","author":"W Diezel","year":"1989","unstructured":"Diezel W, Eckert R, Muller GM, Forner K, Sonnichsen N: Splenopentin influence on antibody formation in immunosuppressed animals andonphagocyticcapability of human granulocytes. Arch Geschwultforsch 1989;59:161\u2013164.","journal-title":"Arch Geschwultforsch"},{"key":"BF02786456_CR138","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1055\/s-0029-1210901","volume":"94","author":"R Eckert","year":"1989","unstructured":"Eckert R, Diezel W, Schmidt R, Forner K, Volk HD: Splenopentin (DAc SP-5) accelerated reconstitution of antibody formation after syngeneic bone marrow transplantation. Exp Clin Endocrinol 1989;94:219\u2013222.","journal-title":"Exp Clin Endocrinol"},{"key":"BF02786456_CR139","first-page":"637","volume":"111","author":"VA Evseev","year":"1991","unstructured":"Evseev VA, Davydova TV, Fomina VG, Odariuk I, Repke H, Oeme P, Forner K: Splenopentin Modulator of immune and behavioral reactions in secondary immunodeficiency state induced by experimental alcoholism. Biull Eskp Biol Med 1991;111:637\u2013639.","journal-title":"Biull Eskp Biol Med"},{"key":"BF02786456_CR140","first-page":"181","volume":"37","author":"HT Liebermann","year":"1993","unstructured":"Liebermann HT, Thalmann G, Bartels T, Nockler A: Experiments on early protection against foot and mouth disease virus. Acta Virol 1993;37:181\u2013183.","journal-title":"Acta Virol"},{"key":"BF02786456_CR141","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1055\/s-0029-1210902","volume":"94","author":"R Eckert","year":"1989","unstructured":"Eckert R, Schmidt R, Volk HD, Diezel W, Sonnichsen N, von Baehr R: Splenopentin induced reconstitution of the immune response after total body irradiation: optimization of treatment regime. Exp Clin Endocrinol 1989;94:223\u2013225.","journal-title":"Exp Clin Endocrinol"},{"key":"BF02786456_CR142","first-page":"279","volume":"35","author":"R Eckert","year":"1989","unstructured":"Eckert R, Volk HD, Deizel W, Maciejewski J, Heipe F, Forner K, von Baehr R: Prevention of graft-vs-host reaction induced immunodeficiency by treatment with splenopentin (DAc-SP-5). Allerg Immunol 1989;35;279\u2013285.","journal-title":"Allerg Immunol"},{"key":"BF02786456_CR143","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1055\/s-0029-1211024","volume":"96","author":"R Eckert","year":"1990","unstructured":"Eckert R, Maciejewski J, Weber H, Volk HD, Deizel W, Forner K, von Baehr R: Splenopentin (DAcSP-5) influence on engraftment and graft vs host reaction after non-H2 bone marrow transplantation in mice. Exp Clin Endocrinol 1990;96:307\u2013313.","journal-title":"Exp Clin Endocrinol"},{"key":"BF02786456_CR144","first-page":"917","volume":"45","author":"HU Simon","year":"1990","unstructured":"Simon HU, Forner K, Buttner A, Haroske D Vogt KH: The lymphocyte transformation test using mononuclear cells of elderly patients as a suitable in vitro method for the estimation of structure effect relationships of splenin peptides. Pharmazie 1990; 45:917\u2013919.","journal-title":"Pharmazie"},{"key":"BF02786456_CR145","first-page":"351","volume":"36","author":"HU Simon","year":"1990","unstructured":"Simon HU, Reipert B, Haroske D, Forner K, Storz H: Age-dependent sensitivity of human lymphocytes to the immunomodulating effect of bovine and human diacetyl splenopentin. Allerg Immunol 1990;36:351\u2013358.","journal-title":"Allerg Immunol"},{"key":"BF02786456_CR146","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0192-0561(93)90035-W","volume":"15","author":"W Diezel","year":"1993","unstructured":"Diezel W, Weber HA, Maciejewski J, Volk HD: The effect of splenopentin (DAc SP-5) on in vitro myelopoiesis and on AZTinduced bone marrow toxicity. Int J Immunopharmacol 1993;15: 269\u2013273.","journal-title":"Int J Immunopharmacol"},{"key":"BF02786456_CR147","first-page":"157","volume":"176","author":"J Greiner","year":"1990","unstructured":"Greiner J, Mihe M, Weber H, Stoimenov A, Sonnichsen N, Diezel W: Therapeutic use of splenopentin (DA SP-5) in patients with psoriasis arthropathica. Dermatol Monatsschr 1990;176:157\u2013162.","journal-title":"Dermatol Monatsschr"},{"key":"BF02786456_CR148","first-page":"634","volume":"74","author":"VF Martynov","year":"1988","unstructured":"Martynov VF, Leont\u2019eva LI, Sorochinskaia El: Effect of synthetic fragments of thymic peptide hormones on learning and memory processes. Fiziol Zh 1988;74:634\u2013639.","journal-title":"Fiziol Zh"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02786456.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02786456\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02786456","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T13:27:25Z","timestamp":1684157245000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02786456"}},"subtitle":["Current status"],"short-title":[],"issued":{"date-parts":[[1998,6]]},"references-count":148,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1998,6]]}},"alternative-id":["BF02786456"],"URL":"https:\/\/doi.org\/10.1007\/bf02786456","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,6]]}}}